Indeed, C13orf18, a gene with a hypermethylation status common to both FOLFOX and FOLFIRI first-line datasets, is frequently hypermethylated and silenced in cervical cancer, and its re-expression results in the growth inhibition of cervical tumor cells [46]. The gene discussed is RUBCNL; the disease is uterine cervix neoplasm.